Dr. Rachel Danis: Fertility Specialist, Researcher, Academic and Patrick Clancy’s Wife
Dr. Rachel Danis is an American reproductive endocrinologist and infertility specialist whose career combines clinical medicine, academic teaching, scientific research and fertility care. She works with Reproductive Medicine Associates of New York and holds an academic role within the Mount Sinai medical system. Her specialist interests include endometriosis, fertility preservation, ovulation induction, assisted reproduction and family-building care.
Beyond medicine, she gained wider attention after marrying Patrick Clancy in 2026. Their relationship brought her name into national media coverage, although her professional achievements long predate that attention. Her work in reproductive endocrinology includes research into elagolix, ovarian stimulation and assisted reproductive technologies, alongside years of medical training at leading American institutions.
Who Is Dr. Rachel Danis?
Dr. Rachel Blair Danis, MD, MS, is a double board-certified physician specialising in obstetrics and gynaecology as well as reproductive endocrinology and infertility. She practises at Reproductive Medicine Associates of New York, commonly known as RMA of New York. Her work centres on helping people understand and manage fertility challenges through evidence-based reproductive medicine.
She also teaches within the Mount Sinai system and has worked with medical students, OBGYN residents and reproductive endocrinology fellows. Her clinical and academic interests overlap strongly, allowing her to combine patient care with research and medical education. This has made her career more varied than that of a physician focused only on private clinical practice.
In 2026, Danis was 37 years old. Her exact date of birth has not been confirmed by an authoritative biographical source, so a precise birthday should not be stated as fact. Her professional identity, however, is well established through medical institutions, research publications and faculty records.
Dr. Rachel Danis Education and Medical Training
Dr. Rachel Danis began her higher education at Barnard College at Columbia University. Her professional education history shows that she studied there from 2006 until 2010. She completed a bachelor’s degree with psychology as her major and Spanish as her minor, giving her an academic background that included both behavioural science and language study.
Medical School at Drexel University
After Barnard College, she entered Drexel University College of Medicine in Philadelphia. She studied medicine from 2010 until 2014 and earned her Doctor of Medicine degree. This stage provided the medical foundation for her later specialisation in women’s health, reproductive medicine and infertility.
She remained within the Drexel and Hahnemann medical system for postgraduate training. From 2014 to 2018, she completed her residency in obstetrics and gynaecology at Hahnemann University Hospital at Drexel University. During the final year of residency, she was nominated administrative chief resident, marking an early leadership achievement in her medical career.
Fellowship at the University of Southern California
After residency, Danis moved into the highly specialised field of reproductive endocrinology and infertility. She completed her fellowship at the Keck School of Medicine of the University of Southern California from 2018 to 2021. Her training focused on reproductive hormones, infertility treatment, ovarian function and assisted reproductive technologies.
At the same time, she completed a Master of Science in Clinical, Biomedical and Translational Investigation at USC. Completing a master’s degree while undertaking a demanding medical fellowship reflected her commitment to academic medicine. It also strengthened her ability to connect scientific research with practical treatment for fertility patients.
Dr. Rachel Danis Career in Reproductive Medicine
Following fellowship training, Danis worked as a reproductive endocrinologist at Kindbody. Her professional history places her there during the early part of her specialist career before she joined RMA of New York. This period gave her further experience in fertility medicine and modern assisted reproduction.
In September 2022, she joined Reproductive Medicine Associates of New York as a physician. RMA is a major fertility centre with locations across the New York area. Her clinical work there includes diagnosing infertility, planning treatment, fertility preservation and managing reproductive conditions that can affect a person’s ability to conceive.
Dr. Rachel Danis is also affiliated with the Icahn School of Medicine at Mount Sinai. She has been described as an Assistant Clinical Professor in the Department of Obstetrics, Gynecology and Reproductive Science. Her role combines direct patient care with teaching, training and academic participation.
Areas of Medical Expertise
Her clinical interests cover a broad range of reproductive health conditions. She has particular expertise in endometriosis, a condition in which tissue similar to the lining of the uterus develops outside the uterus. Endometriosis can cause pain, inflammation and fertility difficulties, making careful management especially important for patients hoping to conceive.
Fertility Preservation and Infertility Treatment
Fertility preservation is another major part of her work. This field can include egg freezing and other strategies designed to preserve reproductive options for the future. Patients may consider fertility preservation for personal reasons, before certain medical treatments, or because of conditions that could affect ovarian function.
She also works with ovulation induction and broader infertility diagnoses. Treatment plans can involve hormone therapy, intrauterine insemination, in vitro fertilisation and other assisted reproductive techniques. Her work also includes family-building care for LGBTQIA+ patients seeking reproductive treatment.
Patient-Centred Reproductive Care
Modern fertility treatment can involve complex medical decisions, emotional pressure and repeated clinical procedures. Danis has written about ways reproductive medicine may reduce the physical burden placed on patients. Her research interest in oral medications reflects a broader focus on making treatment more manageable while maintaining clinical effectiveness.
Dr. Rachel Danis and Elagolix Research
One of the most significant areas of her academic work concerns elagolix, an oral gonadotropin-releasing hormone antagonist. The medication is best known for its use in managing moderate to severe pain associated with endometriosis. Unlike older GnRH agonists, it can suppress reproductive hormone activity quickly.
Danis received an investigator-initiated grant from AbbVie to study elagolix. Her work examined the drug’s pharmacodynamic behaviour during different stages of the natural menstrual cycle. The research explored how effectively the medication could suppress hormonal activity when introduced at different times.
Does Timing Matter When Initiating Elagolix?
In 2021, Dr. Rachel Danis and fellow researchers published work examining whether the timing of elagolix administration affected its ability to suppress reproductive hormones. The research considered its effects during different menstrual-cycle phases. This work became part of a wider discussion about potential applications for oral GnRH antagonists in reproductive medicine.
Her research later supported broader academic discussion about whether elagolix could have uses beyond conventional endometriosis treatment. Danis examined possibilities involving ovarian stimulation, assisted reproductive technology and reproductive hormone control. These questions could influence how fertility treatment develops over time.
Elagolix and the Future of Fertility Treatment
In 2023, Danis wrote an academic editorial titled “Elagolix: How far can it go in the world of gynecology?” The paper explored how an oral GnRH antagonist could potentially change controlled ovarian stimulation. One major advantage discussed was the possibility of reducing the number of injections required during fertility treatment.
Patients undergoing ovarian stimulation can face physical discomfort, treatment anxiety and significant emotional pressure. An oral medication capable of replacing certain injectable drugs could therefore improve the treatment experience. Danis also considered potential cost advantages and the effect that simpler treatment could have on patient compliance.
Wider Possibilities for Elagolix
Her academic discussion also considered possible roles for elagolix in random-start ovarian stimulation and reproductive planning. She explored whether its rapid hormonal suppression could eventually support other clinical uses. However, she also emphasised that more evidence was needed before broader applications could become routine medical practice.
This balanced approach is an important part of her scientific work. Rather than treating experimental possibilities as established treatment, her writing distinguishes between demonstrated results and areas requiring further study. That reflects the evidence-driven standards expected in reproductive medicine.
Research Publications and Academic Work
Danis has contributed to research covering multiple aspects of fertility and reproductive medicine. Her published work has addressed ovarian stimulation, oocyte development, reproductive hormones, fertility preservation, sperm morphology and the effects of reproductive medications. Her papers have appeared in respected medical journals.
Her publication history includes work in Fertility and Sterility, Fertility & Sterility Reports, the Journal of Assisted Reproduction and Genetics and the Journal of Minimally Invasive Gynecology. She has also contributed to research presented at national scientific conferences. This academic activity has continued alongside her clinical career.
Teaching at Mount Sinai
Education forms another important part of her work. Danis has taught medical students, obstetrics and gynaecology residents and reproductive endocrinology fellows. Her teaching includes lectures as well as clinical education during patient care.
She has also been involved with hospital-based reproductive endocrinology clinics. This allows younger doctors to gain experience in fertility medicine while working with established specialists. Her combination of clinical practice, teaching and research gives her a strong academic role within reproductive medicine.
Dr. Rachel Danis Reviews and Professional Recognition
Online patient feedback concerning Danis remains limited compared with the volume of material documenting her professional qualifications. Some medical review platforms contain only a small number of ratings, making it difficult to draw a reliable conclusion about overall patient satisfaction from those scores alone.
Her stronger professional indicators come from her medical training, board certification, research activity and academic appointments. She has also been recognised through New York Rising Stars selections in recent years. Such recognition adds another professional dimension to her career in reproductive medicine.
Personal Life and Interests
Outside medicine, Danis has several interests that feature in her professional biography and social media presence. She enjoys Barry’s Bootcamp, ballet, baking with family and spending time in Central Park. She also has a background in competitive figure skating and speaks Spanish.
Running is particularly important in her personal life. Her Instagram biography describes her as a three-time marathon runner and connects her with Run for Autism, Achilles NYC and New York Road Runners. Her interest in distance running later became directly connected with one of the most important relationships in her life.
Running and Charity Work
Danis participated in the 2024 Honolulu Marathon as part of the RUN FOR AUTISM initiative supporting the Organization for Autism Research. Her fundraising page explained the organisation’s work in autism research, education and community support.
She raised $2,046 and finished as the top individual fundraiser displayed for that event. This involvement shows that her running extends beyond fitness and competition. She has also used marathon participation as a way to support charitable causes.
Dr. Rachel Danis and Patrick Clancy
Dr. Rachel Danis met Patrick Clancy in January 2024 through a running club in New York. Their connection initially developed as a friendship. They spent time running together and having coffee, gradually learning more about each other’s lives.
During their early friendship, Patrick told her about the deaths of his three children. Danis later explained that she had many questions but approached the subject with care. Their friendship eventually became a romantic relationship after several months.
Patrick Clancy’s New Wife Rachel Danis
Patrick and Danis married in April 2026 in Central Park, New York City. Their wedding was a private event, and wider awareness of the marriage came later. Their relationship drew intense media attention because Patrick had previously been married to Lindsay Clancy.
Danis later appeared alongside Patrick in a 2026 60 Minutes interview. During the programme, she discussed their relationship, Patrick’s grief and the challenges created by public attention. She described him as a supportive partner and spoke about building a future together while respecting the memory of his children.
Lindsay Clancy and Rachel Danis
Lindsay Clancy and Danis are connected through Patrick Clancy, but there is no established evidence that the two women share an independent personal relationship. Lindsay is Patrick’s former wife, while Danis is his current wife. Any stronger claim would require reliable evidence.
It is also important not to connect Danis’s elagolix research with Lindsay Clancy’s medical history without evidence. Danis began studying the medication years before she met Patrick. Her published work developed from her professional interest in reproductive endocrinology and endometriosis.
Dr. Rachel Danis Pregnancy and Family Plans
In September 2026, Danis and Patrick spoke publicly about starting a family. Subsequent coverage confirmed that she was pregnant and that the couple were expecting their first child together. This marked a new chapter in their marriage after the considerable attention surrounding Patrick’s earlier family tragedy.
The baby’s name, sex and precise due date have not been confirmed by an authoritative source. Those details should therefore remain private unless the couple chooses to share them. The confirmed point is that Danis and Patrick are expecting a child together.
Social Media Presence
Danis uses Instagram under the name @drrachelbdanis. Her biography identifies her as a double board-certified OBGYN and reproductive endocrinology and infertility specialist. It also highlights her marathon experience and running affiliations.
As of October 2026, the account had close to 1,200 followers. Social media figures change frequently, so they are less important than the account’s professional and personal context. Her Instagram presence reinforces her identity as both a fertility physician and committed distance runner.
Dr. Rachel Danis Net Worth
No credible financial source has established Danis’s personal net worth. Estimates that assign her a specific multimillion-dollar fortune are speculative and should not be presented as fact. Physicians in reproductive endocrinology can earn substantial incomes, but salary averages do not establish the wealth of an individual doctor.
Her financial position has remained private. What can be established confidently is that she has built a successful career within a highly specialised area of medicine. Her work spans clinical fertility care, academic teaching, medical research and professional education.
Final Thoughts on Dr. Rachel Danis
Dr. Rachel Danis has developed a substantial medical career based on specialist fertility care, reproductive endocrinology, scientific research and teaching. Her education at Barnard, Drexel and USC prepared her for a field that requires both advanced clinical knowledge and close attention to patient needs.
Although her marriage to Patrick Clancy brought her far greater public attention, it is only one part of her life. Her work on endometriosis, elagolix, fertility preservation and assisted reproduction shows a long-standing professional commitment to reproductive medicine. Her academic contributions, charity running and teaching work further define a career that extends well beyond the headlines.



